Operating Segments (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)
Segment reporting
Revenues	$ 948,911	$ 824,268
(Loss) Income from Operations	(14,238,904)	(13,098,960)
Amortization and Depreciation Expense	24,562	34,161
Other (Expense) Income, Net	(714,370)	(316,755)
Share-Based Compensation	333,389	361,559
Identifiable Assets	$ 14,279,717	26,869,927
Number of operating segments | segment	2
Operating Segments [Member] | Specialized BioTherapeutics [Member]
Segment reporting
Revenues	$ 31,929
(Loss) Income from Operations	(7,614,988)	(7,216,450)
Amortization and Depreciation Expense	10,087	7,804
Other (Expense) Income, Net	102,320	135,409
Share-Based Compensation	138,075	136,594
Identifiable Assets	103,742	128,645
Operating Segments [Member] | Public Health Solutions [Member]
Segment reporting
Revenues	916,982	824,268
(Loss) Income from Operations	26,612	(542,270)
Amortization and Depreciation Expense	1,681	1,301
Share-Based Compensation	4,804	21,884
Identifiable Assets	121,290	146,296
Corporate [Member]
Segment reporting
(Loss) Income from Operations	(6,650,528)	(5,340,240)
Amortization and Depreciation Expense	12,794	25,056
Other (Expense) Income, Net	(816,690)	(452,164)
Share-Based Compensation	190,510	203,081
Identifiable Assets	$ 14,054,685	$ 26,594,986